References
- Association NT. About Nunavik. 2010. [cited 2011 Sep 12]. Available from: http://www.nunavik-tourism.com/.
- Québec OtsotGo. Nunavik: adventure awaits!. [cited 2011 Sep 12]. Available from: http://www.bonjourquebec.com/qc-en/nunavik0.html.
- Canada S. Aboriginal population profile region du Nunavik. 2006. [cited 2012 Apr 10]. Available from: http://www12.statcan.ca/census-recensement/2006/dp-pd/prof/92-594/details/page.cfm?Lang=E&Geo1=HR&Code1=2417&Geo2=PR&Code2=24&Data=Count&SearchText=Region%20du%20Nunavik&SearchType=Begins&SearchPR=01&B1=All&GeoLevel=PR&GeoCode=2417.
- Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res. 2002; 89: 229–40.
- Chattopadhyay K. A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet. 2011; 17: 132–44.
- de Araujo Souza PS, Sichero L, Maciag PC. HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncol. 2009; 5: 359–70.
- Zhang SY, Gu HX, Li D, Yang SF, Zhong ZH, Li XK, etal. Association of human leukocyte antigen polymorphism with hepatitis B virus infection and genotypes. Jpn J Infect Dis. 2006; 59: 353–7.
- Cangussu LO, Teixeira R, Campos EF, Rampim GF, Mingoti SA, Martins-Filho OA, etal. HLA class II alleles and chronic hepatitis C virus infection. Scand J Immunol. 2011; 74: 282–7.
- Institute NHGR. Talking glossary of genetic terms. [cited 2012 Apr 10]. Available from: http://www.genome.gov/glossary/index.cfm.
- Institute ANR. HLA nomenclature. 2012. [cited 2012 Apr 10]. Available from: http://hla.alleles.org/announcement.html.
- Hamlin-Douglas LK, Coutlee F, Roger M, Franco EL, Brassard P. Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec. Cancer Epidemiol Biomarkers Prev. 2008; 17: 3141–9.
- Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, etal. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens. 1995; 46: 355–67.
- Mahmud SM, Robinson K, Richardson H, Tellier PP, Ferenczy AS, Roger M, etal. HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students. J Infect Dis. 2007; 196: 82–90.
- Ferguson R, Ramanakumar AV, Richardson H, Tellier PP, Coutlee F, Franco EL, etal. Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. Hum Immunol. 2011; 72: 337–41.
- Leffell MS, Fallin MD, Erlich HA, Fernandez-Vijna M, Hildebrand WH, Mack SJ, etal. HLA antigens, alleles and haplotypes among the Yup'ik Alaska natives: report of the ASHI Minority Workshops, Part II. Hum Immunol. 2002; 63: 614–25.
- Ades S, Koushik A, Duarte-Franco E, Mansour N, Arseneau J, Provencher D, etal. Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia. Int J Cancer. 2008; 122: 2820–6.
- Ferguson R, Ramanakumar AV, Koushik A, Coutlee F, Franco E, Roger M. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. Int J Cancer. 2012; 131: E312–9.
- Matte C, Lacaille J, Zijenah L, Ward B, Roger M. HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group. Hum Immunol. 2000; 61: 1150–6.
![Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.]({"type":"image" , "src" : "/sda/112443/Skyscraper-socialsciences.png"})